Current Rating and Its Significance
MarketsMOJO’s 'Buy' rating for Artemis Medicare Services Ltd indicates a positive outlook on the stock’s potential for capital appreciation and overall financial health. This rating, reflecting a Mojo Score of 78.0, suggests that the stock is favourably positioned relative to its peers in the hospital sector. Investors can interpret this as a recommendation to consider adding the stock to their portfolios, based on a comprehensive evaluation of quality, valuation, financial trends, and technical indicators.
Quality Assessment: Strong Operational Fundamentals
As of 26 August 2026, Artemis Medicare Services Ltd demonstrates robust operational quality. The company holds a 'good' quality grade, supported by a consistent track record of positive quarterly results over the last 10 quarters. Its Return on Capital Employed (ROCE) stands at a healthy 14.21% for the half-year period, signalling efficient use of capital to generate profits. Furthermore, the company maintains a low debt-to-equity ratio of 0.28 times, underscoring prudent financial management and a strong ability to service debt obligations. The operating profit to interest coverage ratio of 8.74 times further confirms the company’s capacity to comfortably meet interest expenses, reducing financial risk for investors.
Valuation: Attractive Entry Point Amid Growth
The valuation grade for Artemis Medicare Services Ltd is deemed 'attractive' as of today. The stock trades at a Price to Book Value of 5.5, which, while reflecting growth expectations, remains at a discount compared to its peers’ historical averages. This suggests that the market has not fully priced in the company’s growth potential, offering a favourable entry point for investors. The company’s Return on Equity (ROE) of 11.3% further supports the valuation, indicating efficient utilisation of shareholder funds to generate earnings. Additionally, the PEG ratio of 2.7 balances the company’s strong profit growth with its current market price, signalling reasonable valuation relative to earnings growth prospects.
Financial Trend: Consistent Growth and Profitability
Financially, Artemis Medicare Services Ltd exhibits a positive trend. Operating profit has grown at an annualised rate of 33.45%, reflecting strong business expansion and operational leverage. The company’s market capitalisation remains in the smallcap segment, yet it has delivered impressive returns over multiple time horizons. As of 26 August 2026, the stock has generated a 46.66% return over the past year and a 38.55% gain over the last six months. Year-to-date returns stand at 20.22%, outperforming broader indices such as the BSE500. This market-beating performance is complemented by a steady increase in profits, which have risen by 32.9% over the past year, underscoring sustainable earnings growth.
Technicals: Bullish Momentum Supports Uptrend
The technical grade for Artemis Medicare Services Ltd is classified as 'bullish', reflecting positive price momentum and favourable chart patterns. Recent price movements show a 0.6% gain on the latest trading day, with weekly and monthly returns of 3.74% and 18.11% respectively. The three-month return of 14.70% further confirms the stock’s upward trajectory. This technical strength suggests that investor sentiment remains optimistic, supporting the stock’s potential for continued appreciation in the near term.
Summary of Key Metrics as of 26 August 2026
To summarise, Artemis Medicare Services Ltd presents a compelling investment case based on the following current metrics:
- Mojo Score: 78.0 (Buy grade)
- Debt to EBITDA ratio: 1.39 times, indicating manageable leverage
- Operating profit growth rate: 33.45% annually
- ROCE (Half Year): 14.21%
- Debt-Equity ratio (Half Year): 0.28 times
- Operating profit to interest coverage (Quarterly): 8.74 times
- ROE: 11.3%
- Price to Book Value: 5.5
- PEG ratio: 2.7
- Returns: 1 Year +46.66%, 6 Months +38.55%, YTD +20.22%
These figures collectively highlight a company with strong fundamentals, attractive valuation, positive financial momentum, and technical strength, justifying the current 'Buy' rating.
Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!
- - Clear entry/exit targets
- - Target price revealed
- - Detailed report available
What This Rating Means for Investors
For investors, the 'Buy' rating on Artemis Medicare Services Ltd signals confidence in the company’s ability to deliver value through both capital gains and steady financial performance. The rating reflects a balanced assessment of quality, valuation, financial trends, and technical factors, providing a comprehensive view of the stock’s investment potential. Investors should consider this rating as an endorsement of the company’s current fundamentals and market position, while also recognising the inherent risks associated with smallcap stocks in the hospital sector.
Sector Context and Market Position
Operating within the hospital sector, Artemis Medicare Services Ltd benefits from structural growth drivers such as increasing healthcare demand and rising medical infrastructure investments. The company’s strong operational metrics and disciplined financial management position it well to capitalise on these trends. Compared to its sector peers, Artemis’s valuation remains attractive, offering a compelling risk-reward profile for investors seeking exposure to healthcare services.
Conclusion
In conclusion, Artemis Medicare Services Ltd’s current 'Buy' rating by MarketsMOJO, last updated on 08 June 2026, is supported by a solid foundation of quality operations, attractive valuation, positive financial trends, and bullish technical indicators as of 26 August 2026. This comprehensive analysis provides investors with a clear rationale for considering the stock as part of a diversified portfolio focused on growth and stability within the hospital sector.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
